MPC
44
8
PAYX
44
2
LB
64
9
HD
41
3
HST
34
2
COF
49
2
GPC
53
2
AMAT
36
6
PLD
48
5
BWA
36
3
ADBE
44
4
C
51
3
MTCH
48
4
KIM
54
3
EQT
59
5
CRM
39
5
PPG
45
4
GLW
49
3
ESS
59
5
V
46
2
MPC
44
8
PAYX
44
2
LB
64
9
HD
41
3
HST
34
2
COF
49
2
GPC
53
2
AMAT
36
6
PLD
48
5
BWA
36
3
ADBE
44
4
C
51
3
MTCH
48
4
KIM
54
3
EQT
59
5
CRM
39
5
PPG
45
4
GLW
49
3
ESS
59
5
V
46
2
Financhill
Back

Paycom Software 10K Form

Sell
49

PAYC
Paycom Software

Last Price:
$215.97
Seasonality Move:
9.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PAYC News And Ratings

See the #1 stock for the next 7 days that we like better than PAYC

PAYC Financial Statistics

Sales & Book Value

Annual Sales: $1.9B
Cash Flow: $104.6M
Price / Cash Flow: 34.82
Annual Sales: $28.23
Price / Book: 7.39

Profitability

EPS (TTM): 8.90000
Net Income (TTM): $502M
Gross Margin: $1.5B
Return on Equity: 34.82%
Return on Assets: 11.11%

Paycom Software Earnings Forecast

Key Paycom Software Financial Ratios

  • The Gross Profit Margin over the past 14 years for PAYC is 82.23%.
  • The Selling, General & Administrative Expenses for PAYC have been equal to 31.49% of Gross Profit Margin.
  • The Research & Development expenses have been 12.88% of Revenue.
  • The Interest Expense is 0.68% of Operating Income.
  • The Net Earning history of PAYC is 26.66% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 11 years.

Paycom Software Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Professional Services
Sector: Industrials
Current Symbol: PAYC
CUSIP: 70432V
Website: paycom.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.1
Quick Ratio: 0.12

Price-to-Earnings

Trailing P/E Ratio: 23.32
Forward P/E Ratio: 21.41

PAYC Technical Analysis vs Fundamental Analysis

Sell
49
Paycom Software (PAYC) is a Sell

Is Paycom Software a Buy or a Sell?

  • Paycom Software stock is rated a Sell
    The current Paycom Software [PAYC] share price is $207.99. The Score for PAYC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.